Search

everythinglearnresearchcommunity

for

Search:↓

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Intramuscular injections improved hair density more than intradermal injections for treating hair loss.

PRP injections improve hair density in men with hair loss, with few short-term side effects.

Microneedling with either platelet-rich plasma or 5% minoxidil can increase hair growth in people with androgenetic alopecia, but minoxidil might be slightly better.

People with Myotonic Dystrophy type 1 are more likely to have certain skin conditions, but not more likely to get skin cancer.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Hair loss treatment caused more hair loss in a man.

PRP is more effective than minoxidil and placebo for treating hair loss.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Pumpkin seed oil may help hair growth, but more research needed on frontal hair loss and long-term effects.

AA-PRP temporarily increases hair density in androgenetic alopecia but loses effectiveness over time.

EF and PXE not closely related.

Bald men may have higher heart disease risk.

Alopecia patients struggle with emotions and stress, and improving emotional intelligence may help manage hair loss.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Low-level laser therapy can stimulate hair growth more effectively than fake devices, but patient satisfaction is similar for both. Results should be taken with caution due to small study sizes and differences between studies. More research is needed.

No CD44 in alopecia areata, present in normal and androgenetic alopecia.

Biopsy can differentiate between alopecia areata and androgenic alopecia, and if more information is needed, testing for CD3 and CD8 can help.

Scalp biopsies help tell apart androgenetic alopecia and alopecia areata.

Ludwig pattern hair loss in women results from varying sensitivity in hair follicles, causing fewer visible hairs.

Early balding at 40 increases prostate cancer risk.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Erbium YAG laser treatment, combined with conventional therapy, can effectively reduce hair loss and promote hair growth in men with androgenetic alopecia.